Human milk antitumor agent

20 August 1995

- Swedish scientists believe they have discovered a compound in human milk that specifically induces apotosis in transformed (often precancerous) and immature mammalian cells, it was revealed in the Proceedings of the National Academy of Sciences, published August 15. The researchers have identified the active agent as a multimeric form of the common milk protein alpha-lactalbumin - the monomer is inactive - and are optimistic that analysis of the compound's mechanism of action will lead to the design of new antitumor agents.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight